Crown (CCK) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
28 Oct, 2026Executive summary
Global beverage-can shipments rose 6% in Q3; adjusted diluted EPS increased 7% YoY to $2.39 despite inflation and weaker Transit Packaging results.
Net sales reached $3,711M; FY2026 guidance calls for adjusted diluted EPS of $8.35–$8.45 and adjusted free cash flow of at least $950M.
Financial highlights
Q3 net sales were $3,711M vs. $3,202M; operating income was $442M vs. $423M, and net income attributable to shareholders was $225M vs. $214M.
Q3 diluted EPS was $2.08 vs. $1.85; adjusted diluted EPS was $2.39 vs. $2.24. Higher shipments and $405M of material-cost pass-through contributed to sales growth.
9M net sales were $10,638M vs. $9,238M; operating income was $1,271M vs. $1,179M, and adjusted diluted EPS was $6.72 vs. $6.05.
Q3 segment income was $484M vs. $490M as volume gains were offset by input-cost inflation and lower Transit Packaging results.
9M cash from operations was $1,065M; capital expenditures were $310M and adjusted free cash flow was $771M.
Outlook and guidance
FY2026 adjusted diluted EPS guidance is $8.35–$8.45; Q4 adjusted diluted EPS guidance is $1.63–$1.73.
FY2026 adjusted free cash flow is expected to be at least $950M, with capex of ~$550M and year-end adjusted net leverage of ~2.5x.
Global beverage-can volume growth is forecast at 4%–5% for FY2026 and 3.5%–4% in Q4; North America is expected to be capacity constrained and sold out in 2027.
2027 regional beverage-can volume growth outlook: Europe 2%–5%; Asia low- to mid-single digits.
Contractual repricing, mostly around April 1, 2027, is expected to recover much of 2026’s inflation headwind; management estimated about half of the cited impact would be recouped.
Latest events from Crown
- Record 2025 results, strong sustainability, and 2026 growth outlook with higher dividends.CCK
AGM presentation - Record financial results, sustainability leadership, and strong 2026 growth outlook.CCK
AGM presentation - Q2 net sales and adjusted EPS up 16% year-over-year; full-year guidance raised on strong demand.CCK
Q2 2026 - Adjusted EPS up 11% and net sales up 13% on strong global beverage can demand and India expansion.CCK
Q1 2026 - Board recommends director elections, auditor ratification, pay approval, and opposes written consent.CCK
Proxy filing - Record adjusted EBITDA, strong free cash flow, and robust shareholder returns highlight 2025 results.CCK
Q4 2025 - Q3 2025 delivered higher adjusted EPS, strong European growth, and raised full-year guidance.CCK
Q3 2025 - Q2 adjusted EPS up 19%, guidance raised, and robust share repurchases and cash flow outlook.CCK
Q2 2025 - Strong global beverage can growth, higher earnings, and a $2B buyback program announced.CCK
Q2 2024